(TCDA) - Management Comments

(TCDA) – Management Comments

Feb 25, 2021 05:22 PM Tricida (TCDA) Tops Q4 EPS by 3c
Aug 24, 2020 08:31 AM Tricida (TCDA) Receives CRL from FDA for its NDA for Veverimer for Treatment of Metabolic Acidosis and Slowing of Kidney Disease Progression in Patients with Metabolic Acidosis Associated with CKD
Aug 5, 2020 05:28 PM
May 7, 2020 05:11 PM
Feb 27, 2020 04:51 PM
Nov 14, 2019 04:15 PM
Aug 8, 2019 04:40 PM
Jun 25, 2019 08:31 AM
May 8, 2019 04:15 PM
Mar 11, 2019 08:33 AM
Nov 8, 2018 04:35 PM
Aug 8, 2018 04:14 PM